<

 
Data updated 2025-08-08 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date03752058.2 (espacenet)  (Federated)  (European Patent Register), 20030905
Patent/reg. no. and dateDK/EP 1572946, 20120314
Publication date20050914
Priority no. and dateUS 408719 P, 20020906
EP pub. no. and date EP 1572946 20050914
Effective date
Applicant/ownerAmgen, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US,
E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road
Princeton, NJ 08540, US
Applicant ref. no.63401
InventorVARNUM, Brian, 602 12th Street
Santa Monica, CA 90402, US,
VEZINA, Chris, 351 South Greenway Avenue
Newbury Park, CA 91320, US,
QIAN, Xueming, 596 Myrtle Court
Oak Park, CA 91320, US,
ELLIOTT, Gary, 2458 Chaucer Place
Thousand Oaks, CA 91362, US,
HUANG, Haichun, 2425 Sueno Way
Fremont, CA 94539, US,
MARTIN, Frank, 865 Fernhill Court
Newbury Park, CA 91320, US,
WITTE, Alison, 3505 Bean Creek Road
Scotts Valley, CA 95066, US
RepresentativeLarsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V
Opponent
IPC ClassA61K 39/395 (2006.01) , C07K 16/28 (2006.01) 
TitleTerapeutisk humant monoklonalt anti-IL-1R1-antistof
Int. application no.US2003027978
Int. publication no.WO2004022718
Related patent (certificate)
StatusUdløbet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact